By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Swedish Orphan Biovitrum 

SE-112

  76  Stockholm  Sweden
Phone: 46-8-697-20-00 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical






Company News
Sobi: Elocta Obtains National Reimbursement In Spain, Now Available In The Five Largest Markets In The EU 9/23/2016 8:37:09 AM
New Number Of Shares And Votes In Sobi 8/31/2016 11:15:08 AM
Sobi’s CEO Divests A Portion Of Shares 8/8/2016 11:02:33 AM
Biogen (BIIB) And Sobi To Showcase Long-Term Efficacy And Safety Data From Extended Half-Life Hemophilia Therapies At World Federation Of Hemophilia 2016 World Congress 7/18/2016 9:58:01 AM
Sobi Release: FDA Approves ORFADIN (Nitisinone) Oral Suspension 4/27/2016 6:09:52 AM
Sobi Partners With U.S. And Canadian Advocates, Legislators To Raise Awareness On Rare Disease Day 2/29/2016 9:56:27 AM
Invitation - Presentation Of Sobi's Third Quarter Results 2015 10/20/2015 12:27:23 PM
Biogen (BIIB) and Sobi Release: Haemophilia Therapy From Largest Multi-Year Donation Now Available To Patients In Developing World 10/12/2015 9:42:53 AM
Sobi CEO Invests In 2015 LTI Programme And Divests A Portion Of Incentive Shares 9/29/2015 9:19:27 AM
Biogen (BIIB) And Sobi Receive Positive Opinion From CHMP For ELOCTA (Rfviiifc) For The Treatment Of Hemophilia A 9/25/2015 10:41:57 AM
12345678910
//-->